Drug Ther Bull. 2014 Aug;52(8):93-6. doi: 10.1136/dtb.2014.8.0273.
▼Relvar Ellipta (GSK) is a dry powder inhaler that contains a corticosteroid (fluticasone furoate) and a long-acting beta2 agonist (vilanterol trifenatate). It is licensed for once-daily use as maintenance therapy for chronic obstructive pulmonary disease (COPD) and asthma. In a previous article we considered its use in the management of COPD.1 Here we review the evidence for Relvar Ellipta in the treatment of patients with asthma.
▼Relvar Ellipta（葛兰素史克公司生产）是一种干粉吸入器，含有一种皮质类固醇（糠酸氟替卡松）和一种长效β2受体激动剂（三苯乙酸维兰特罗）。它被批准用于慢性阻塞性肺疾病（COPD）和哮喘的每日一次维持治疗。在之前的一篇文章中，我们探讨了它在COPD管理中的应用。1 在此，我们回顾Relvar Ellipta治疗哮喘患者的证据。
Zotero 插件